Cabotegravir/rilpivirine is a long-acting injectable for HIV infection, used in patients who have attained viral suppression on another antiretroviral regimen. Drugs that induce cytochrome CYP3A enzymes significantly decrease plasma concentrations of cabotegravir and/or rilpivirine, which may cause a dangerous loss of virologic response. These drugs include rifampin, dexamethasone, and oxcarbazepine.
Learn more about cabotegravir/rilpivirine.
This Rapid Review Quiz was excerpted and adapted from the Medscape articles: Warfarin, Atorvastatin, Real-World Data Suggest Coprescribing PDE5 Inhibitors and Nitrates May Be Safe, Nitroglycerin PO, Spironolactone, Hyperkalemia, Ciprofloxacin, and Theophylline Toxicity.
Lead image: Cinepro | Dreamstime.com
Medscape © 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Mary L. Windle. Rapid Rx Quiz: Dangerous Drug Combinations - Medscape - Mar 13, 2023.